Jim P Buttery

Summary

Affiliation: Royal Children's Hospital
Country: Australia

Publications

  1. ncbi Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial
    Jim P Buttery
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford, UK
    JAMA 293:1751-8. 2005
  2. ncbi Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia
    J P Buttery
    SAEFVIC in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Parkville, Victoria 3052, Australia
    Vaccine 29:3061-6. 2011
  3. ncbi Mass psychogenic response to human papillomavirus vaccination
    Jim P Buttery
    SAEFVIC, Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne, Vic, Australia
    Med J Aust 189:261-2. 2008
  4. ncbi A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge ph
    Anna Riddell
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, UK
    Vaccine 25:3906-12. 2007
  5. ncbi Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination
    Celeste M Donato
    Enteric Virus Group, Murdoch Childrens Research Institute, Royal Children s Hospital, Melbourne, Australia
    J Infect Dis 206:377-83. 2012
  6. ncbi An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease
    Nigel W Crawford
    SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria 3011, Australia
    BMC Gastroenterol 11:87. 2011
  7. ncbi Recurrent apnoea post immunisation: Informing re-immunisation policy
    Vanessa Clifford
    SAEFVIC, Murdoch Children s Research Institute, Melbourne, Australia
    Vaccine 29:5681-7. 2011
  8. ncbi Survivors of childhood cancer: an Australian audit of vaccination status after treatment
    Nigel W Crawford
    NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunization, Parkville, Vic, Australia
    Pediatr Blood Cancer 54:128-33. 2010
  9. ncbi Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria
    Hazel J Clothier
    SAEFVIC, Murdoch Childrens Research Institute, Parkville, Victoria
    Commun Dis Intell 35:294-8. 2011
  10. ncbi Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule
    Jim P Buttery
    Department of General Medicine and Murdoch Children s Research Institute, Royal Children s Hospital Melbourne, Parkville, Victoria, Australia Paediatric Infectious Diseases Unit, Monash Children s Hospital, Department of Paediatrics, Monash University, Melbourne, Victoria
    Pediatr Infect Dis J 30:S25-9. 2011

Collaborators

Detail Information

Publications21

  1. ncbi Immunogenicity and safety of a combination pneumococcal-meningococcal vaccine in infants: a randomized controlled trial
    Jim P Buttery
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford, UK
    JAMA 293:1751-8. 2005
    ....
  2. ncbi Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia
    J P Buttery
    SAEFVIC in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Parkville, Victoria 3052, Australia
    Vaccine 29:3061-6. 2011
    ..In Australia, post-marketing surveillance for intussusception following vaccination commenced with funding of RotaTeq(®) and Rotarix(®) vaccines under the National Immunization Program (NIP) in July 2007...
  3. ncbi Mass psychogenic response to human papillomavirus vaccination
    Jim P Buttery
    SAEFVIC, Murdoch Childrens Research Institute, Royal Children's Hospital, and Department of Paediatrics, University of Melbourne, Melbourne, Vic, Australia
    Med J Aust 189:261-2. 2008
  4. ncbi A randomized study comparing the safety and immunogenicity of a conjugate vaccine combination containing meningococcal group C and pneumococcal capsular polysaccharide--CRM197 with a meningococcal group C conjugate vaccine in healthy infants: challenge ph
    Anna Riddell
    Oxford Vaccine Group, Centre for Clinical Vaccinology and Tropical Medicine, Department of Paediatrics, University of Oxford, Churchill Hospital, Headington, Oxford OX3 7LJ, UK
    Vaccine 25:3906-12. 2007
    ..This study describes the persistence of immunity at 12 months of age and the immunologic response to a challenge dose of either meningococcal polysaccharide vaccine (Meningivac A+C; MnA+C), or MenC...
  5. ncbi Identification of strains of RotaTeq rotavirus vaccine in infants with gastroenteritis following routine vaccination
    Celeste M Donato
    Enteric Virus Group, Murdoch Childrens Research Institute, Royal Children s Hospital, Melbourne, Australia
    J Infect Dis 206:377-83. 2012
    ..This study identified and characterised rotavirus strains excreted by infants who presented with symptoms of gastroenteritis following recent RotaTeq vaccination...
  6. ncbi An Australian audit of vaccination status in children and adolescents with inflammatory bowel disease
    Nigel W Crawford
    SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria 3011, Australia
    BMC Gastroenterol 11:87. 2011
    ..The primary aim of this study was to describe compliance with current Australian guidelines for vaccination of children and adolescents diagnosed with IBD. A secondary aim was to review the serological screening for VPD...
  7. ncbi Recurrent apnoea post immunisation: Informing re-immunisation policy
    Vanessa Clifford
    SAEFVIC, Murdoch Children s Research Institute, Melbourne, Australia
    Vaccine 29:5681-7. 2011
    ..The risk factors for, and recurrence rate of apnoea with subsequent immunisations are unknown, which makes planning for subsequent immunisations for these highly vulnerable infants difficult...
  8. ncbi Survivors of childhood cancer: an Australian audit of vaccination status after treatment
    Nigel W Crawford
    NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunization, Parkville, Vic, Australia
    Pediatr Blood Cancer 54:128-33. 2010
    ..The aim of this study was to describe the compliance of post-chemotherapy revaccination of childhood cancer survivors relative to current Australian guidelines...
  9. ncbi Surveillance of adverse events following immunisation: the model of SAEFVIC, Victoria
    Hazel J Clothier
    SAEFVIC, Murdoch Childrens Research Institute, Parkville, Victoria
    Commun Dis Intell 35:294-8. 2011
    ..6 per 100,000 in 2003 to 13.5 per 100,000 per annum in 2009. This report describes the SAEFVIC service model and summarises outcomes and lessons learnt in the first 3 years of operation...
  10. ncbi Reduction in rotavirus-associated acute gastroenteritis following introduction of rotavirus vaccine into Australia's National Childhood vaccine schedule
    Jim P Buttery
    Department of General Medicine and Murdoch Children s Research Institute, Royal Children s Hospital Melbourne, Parkville, Victoria, Australia Paediatric Infectious Diseases Unit, Monash Children s Hospital, Department of Paediatrics, Monash University, Melbourne, Victoria
    Pediatr Infect Dis J 30:S25-9. 2011
    ..This allowed comparison of both vaccines in similar populations with high infant vaccination coverage...
  11. ncbi Immunisation practices in infants born prematurely: neonatologists' survey and clinical audit
    Nigel W Crawford
    National Health and Medical Research Council NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Department of General Medicine, Royal Children s Hospital RCH, Parkville, Victoria, Australia
    J Paediatr Child Health 45:602-9. 2009
    ..To determine Australian neonatologists' recommendations for the immunisation of ex-preterm infants and compare their actual immunisation status with recommended Australian guidelines...
  12. ncbi Combination conjugate vaccines
    Naor Bar-Zeev
    Department of General Medicine, Royal Children's Hospital, Melbourne, Australia
    Expert Opin Drug Saf 5:351-60. 2006
    ..The implications of these findings for different communities are discussed, key areas for further research identified and implications for post-licensure monitoring addressed...
  13. ncbi Immunisation practices of paediatric oncologists: an Australasian survey
    Nigel W Crawford
    NHMRC Centre for Clinical Research Excellence in Child and Adolescent Immunisation Murdoch Children s Research Institute, Royal Children s Hospital, Melbourne, Victoria, Australia
    J Paediatr Child Health 43:593-6. 2007
    ..The aim of this survey was to identify the current practices of paediatric oncologists in Australia and New Zealand regarding the immunisation of children treated for cancer...
  14. ncbi Syncope and seizures following human papillomavirus vaccination: a retrospective case series
    Nigel W Crawford
    Murdoch Childrens Research Institute, Melbourne, Vic, Australia
    Med J Aust 194:16-8. 2011
    ..To quantify and characterise the reports of syncope and seizures following quadrivalent (4v) human papillomavirus (HPV) vaccination...
  15. ncbi Mumps vaccine associated orchitis: Evidence supporting a potential immune-mediated mechanism
    Vanessa Clifford
    Infectious Diseases Unit, Department of General Medicine and Murdoch Childrens Research Institute, Royal Children s Hospital Melbourne, Parkville, Victoria 3052, Australia
    Vaccine 28:2671-3. 2010
    ..These cases, discussed together with a comprehensive review of the existing literature regarding post-vaccine orchitis, highlight uncertainty regarding the pathogenesis of post-vaccine orchitis...
  16. ncbi Optimizing immunization in pediatric special risk groups
    Nigel W Crawford
    SAEFVIC, Murdoch Childrens Research Institute, Melbourne, Australia
    Expert Rev Vaccines 10:175-86. 2011
    ..g., varicella, influenza and pertussis vaccination). Improving timeliness and minimizing missed opportunities to vaccinate individuals with these special risk conditions will also optimize protection from vaccine-preventable diseases...
  17. ncbi Rotavirus vaccines in developed countries
    Jim P Buttery
    NHMRC Centre of Clinical Research Excellence in Child and Adolescent Immunisation, Murdoch Children s Research Institute, Infectious Diseases Unit, Royal Children s Hospital, Parkville, Australia
    Curr Opin Infect Dis 20:253-8. 2007
    ..The recent licensure in many nations of vaccines against rotavirus offers promise to significantly reduce this toll. The present review describes recent developments regarding rotavirus vaccines and the challenges they face...
  18. ncbi Complex regional pain syndrome following immunisation
    Stephanie Richards
    SAEFVIC, Department of General Medicine, Royal Children s Hospital RCH, Melbourne, Victoria, Australia
    Arch Dis Child 97:913-5. 2012
    ..Enhanced awareness of this syndrome and its potential to occur following immunisation in the paediatric population is vital to the prompt and effective management of this condition...
  19. ncbi Recurrent 6th nerve palsy in a child following different live attenuated vaccines: case report
    Daryl R Cheng
    Central Medical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
    BMC Infect Dis 12:105. 2012
    ..It has also been temporally associated with immunization, but has not been previously described following two different live attenuated vaccines...
  20. ncbi Minimising missed opportunities to vaccinate
    Nigel W Crawford
    J Paediatr Child Health 44:315-6. 2008
  21. ncbi Immunogenicity and immunologic memory of meningococcal C conjugate vaccine in premature infants
    Clare L Collins
    St. George's Hospital Medical School, London, United Kingdom
    Pediatr Infect Dis J 24:966-8. 2005
    ..K. infants suggest a role for a routine booster dose of vaccine in all infants receiving MCC, especially those born preterm...